From: Splenectomy for hypersplenism with or without preoperative splenic artery embolisation
Study group (n = 50) | Control group (n = 50) | p value | ||
---|---|---|---|---|
Age (years, mean ± SD (range)) | 38 ± 8.1 (28–62) | 34 ± 7.8 (25–60) | 0.893 | |
Gender (n (%)) | Male | 23 (46) | 20 (40) | 0.686 |
Female | 27 (54) | 30 (60) | ||
Splenic size (cm, mean ± SD (range)) | 16.2 ± 3.9 (13–26) | 16.4 ± 4.8 (13–25) | 0.685 | |
Child-Pugh class (n (%)) | A | 47 (94) | 48 (96) | |
B | 3 (6) | 2 (4) | ||
C | 0 | 0 | ||
Co-morbidities (n (%)) | DM | 7 (14) | 6 (12) | 0.659 |
Cholestasis | 17 (34) | 15 (30) | 0.365 | |
Hypertension | 3 (6) | 4 (8) | 0.786 | |
CBC (mean ± SD (range)) | ||||
Platelet (U/μL) | 8500 ± 2444 (6500–18,600) | 9200 ± 2765 (6500–17,400) | 0.646 | |
WBCs (U/μL) | 2700 ± 549 (1150–3200) | 2580 ± 642 (1190–3140) | 0.413 | |
HB (gm/dL) | 8.3 ± 0.79 (7.5–10.8) | 8.5 ± 0.82 (7.8–10.4) | 0.250 | |
Liver function tests (mean ± SD (range)) | ||||
ALT (U/μL) | 72.8 ± 3.5 (67.2–79.5) | 73.4 ± 3.7 (65.8–78.6) | 0.359 | |
AST (U/μL) | 70.6 ± 2.1 (66.8–79.2) | 71.2 ± 2.9 (67.4–77.9) | 0.329 | |
TB (μmol/L) | 23.4 ± 3.3 (18.5–29.4) | 22.8 ± 3.2 (18.9–28.6) | 0.257 |